Allozymes
Allozymes unlocks enzyme potential using microfluidics, building the largest enzyme data set, and achieving 10x faster and cheaper development with 200x higher chance of success.
In our modern world, all ingredients are manufactured, either through chemical processes or through their extraction from plants or animals. Chemical processes are highly polluting, and current methods of isolating natural ingredients from plants and animals are also damaging the environment. These processes typically use significant volumes of biomass, energy, water and land, to grow, harvest, process, and extract the tiniest amounts of natural ingredients.
Allozymes employs proprietary microfluidics technology to build the next generation enzyme engineering platform. This platform can build and test millions of enzymes per day, boosting the likelihood of success of developing the most effective enzymes by 200x. Allozymes has developed oxidases, reductases, isomerases, and hydrolases for its customers, and has done so 10x faster compared to robotics technology.
Founders
Dr Peyman Salehian
Cofounder
Dr. Peyman is a scientist-entrepreneur with extensive experience in transferring technologies from the lab to the market. He completed a PhD at the National University of Singapore, during which he led industrial-academic collaborations focusing on bioprocesses and process scale-up.
Dr Akbar Vahidi
Co-founder
Dr. Akbar is a scientist-entrepreneur and received his PhD in Biocatalysis from the National University of Singapore. He invented Allozymes’ technology when he was working as a lead research fellow at NUS. Akbar has more than 10 years of experience in various aspects of enzyme technology and has delivered several industrial projects for various sectors such as pharma, food, and feed.
Milestones
Founded at Entrepreneur First
Seed ($5 million) led by Xora Innovation
Series A led by Xora Innovation